DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.56 Cr | ₹29 Cr | ₹61 Cr | ₹125 Cr | ₹182 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.56 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹125 Cr |
| Mar2021 | ₹182 Cr |
How is Deferred Tax Assets / Liabilities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.56 Cr | Negative | |
| Mar2024 | ₹29 Cr | -53.14 | |
| Mar2023 | ₹61 Cr | -51.39 | |
| Mar2022 | ₹125 Cr | -30.97 | |
| Mar2021 | ₹182 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹4,149.7 Cr | 20.6% | 6.7% | -17.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,705.0 Cr | -0.7% | 2% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,091.0 Cr | -2.1% | -2.8% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,555.0 Cr | -0.9% | -0.6% | 12.2% | Stock Analytics | |
| CIPLA | ₹120,919.0 Cr | -1% | -1.2% | 3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,165.0 Cr | -0.1% | 2.3% | 2.6% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 20.6% |
6.7% |
-17.5% |
| SENSEX | 0.2% |
-0.5% |
4% |
You may also like the below Video Courses